ag凯发k8真人娱乐注册网站

Biotech Fluidics has published a practical review paper that demonstrates how its MarvelX™ and MarvelXACT™ high pressure fluidic connections enable users to achieve reliable, repeatable, and consistent UHPLC performance. In this paper, fluidic experts explore the connection challenges facing users of modern UHPLC 黄金城游戏s.

One of the biggest challenges in designing high performance fluidic connections for UHPLC is ensuring a reliable seal at the bottom of the connection port. The novel design of MarvelX™ and MarvelXACT™ reduce the sealing area needed to make a connection capable of withstanding UHPLC pressures and significantly decreases the amount of force needed to properly install a connection.

Data is shown that demonstrates how the unique design of MarvelX™ and MarvelXACT™ fittings simplifies and speeds installation without sacrificing high performance. By changing the sealing mechanism and drastically decreasing required installation force, MarvelX™ and MarvelXACT™ fittings also remove the potential to damage critical UHPLC 黄金城游戏 components.

Benefiting from a torque limiting mechanism that ensures fittings cannot be overtightened, data is shown that shows how MarvelXACT™ high-pressure fluidic fittings enable users to achieve repeatable and consistent performance at pressures up to 19,000 psi even after 100 repeat uses.

By simplifying and speeding installation without sacrificing high performance even after many repeat uses, and eliminating damage to UHPLC 黄金城游戏s components, MarvelX™ and MarvelXACT™ fittings potentially provide UHPLC labs with savings of thousands of Euros per year.

To download this practical review paper please visit or contact Biotech Fluidics on + 46 300 56 91 80 / + 612-703-5718 /[email protected].

---------------------

Worldwide HQ

Biotech Fluidics AB
Raovagen 300
439 92 Onsala
Sweden
Tel: +46-300-56-9180
Email: [email protected]
Web: www.biotechfluidics.com